1. Search Result
Search Result
Results for "

SAR

" in MedChemExpress (MCE) Product Catalog:

983

Inhibitors & Agonists

3

Screening Libraries

5

Fluorescent Dye

5

Biochemical Assay Reagents

63

Peptides

60

Inhibitory Antibodies

94

Natural
Products

3

Recombinant Proteins

79

Isotope-Labeled Compounds

6

Antibodies

10

Click Chemistry

17

Oligonucleotides

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-P2381
    Sar-Arg-Val-Tyr-Val-His-NH2
    1 Publications Verification

    Angiotensin Receptor Others
    Sar-Arg-Val-Tyr-Val-His-NH2 is a Gq-biased agonists, exhibits 10-fold larger molecular efficacies at the AT1R-Gq fusion protein compared with the AT1R-βarr2 fusion protein .
    Sar-Arg-Val-Tyr-Val-His-NH2
  • HY-100195
    SAR-020106
    1 Publications Verification

    Checkpoint Kinase (Chk) Cancer
    SAR-020106 is an ATP-competitive, potent, and selective CHK1 inhibitor with an IC50 of 13.3 nM for human CHK1. SAR-020106 shows excellent selectivity over CHK2. SAR-020106 significantly enhances the cell killing of Gemcitabine and SN38 by 3- to 29-fold in several colon tumor lines and in a p53-dependent fashion. SAR-020106 can enhance antitumor activity with selected anticancer agents .
    SAR-020106
  • HY-14830

    Albitiazolium bromide

    Parasite Infection
    SAR 97276 (Albitiazolium bromide) is an antimalarial agent. SAR 97276 interfers with the phospholipid metabolism of malarial parasites, especially the biosynthesis of phosphatidylcholine (PC). SAR 97276 enters erythrocytes through the new permeability pathways (NPP) of infected erythrocytes, and is transported into the malarial parasite by a poly-specific cation carrier .
    SAR 97276
  • HY-15837

    PI3K Cancer
    SAR-260301 is an orally available and selective PI3Kβ inhibitor with an IC50 of 23 nM .
    SAR-260301
  • HY-12481A

    PI3K Cancer
    SAR405 R enantiomer is the less active enantiomer of SAR405. SAR405 is a PIK3C3/Vps34 inhibitor.
    SAR405 R enantiomer
  • HY-P991587

    Orphan GPCR Cancer
    SAR-446523 is a humanized IgG1 monoclonal antibody inhibitor targeting GPRC5D. SAR-446523 significantly induces antibody-dependent cell-mediated cytotoxicity (ADCC). SAR-446523 has potent antitumor activity with improvement of mouse survival in NK humanized NOG huIL15 transgenic mice model bearing MM cells. SAR-446523 can be used for multiple myeloma (MM) research .
    SAR-446523
  • HY-P991382

    TGF-β Receptor Cancer
    SAR-439459 is a human monoclonal antibody (mAb) targeting TGFB1/TGFβ-1. SAR-439459 blocks TGFβ-mediated pSMAD signaling, and suppression of T cells and NK cells. SAR-439459 has anti-tumor activity .
    SAR-439459
  • HY-158569

    Endogenous Metabolite Others
    SAR114137 is a highly effective drug with potent biological activity. SAR114137 exhibits altered amorphous content characteristics during physical processing of the crystalline active pharmaceutical ingredient. The amorphous API content of SAR114137 is significantly reduced when processed by different jet grinding techniques. SAR114137 exhibits good chemical stability in pharmaceutical formulations .
    SAR114137
  • HY-110265

    P2Y Receptor Inflammation/Immunology
    SAR216471 hydrochloride is a P2Y12 receptor antagonist. SAR216471 hydrochloride has antiplatelet and antithrombotic activities in vivo .
    SAR216471 hydrochloride
  • HY-12476

    Phosphodiesterase (PDE) Aurora Kinase Cancer
    SAR156497 (compound 47) is an Aurora inhibitor, with IC50 values ​​of 0.6 nM and 1 nM for Aurora A and Aurora B, respectively. SAR156497 can also inhibit PDE3, with IC50 value of 4 μM. SAR156497 can be used in anticancer research .
    SAR156497
  • HY-P10031

    GLP Receptor GCGR Metabolic Disease
    SAR441255 is a potent unimolecular peptide GLP-1/GIP/GCG receptor triagonist. SAR441255 displays high potency with balanced activation of all three target receptors.?SAR441255 shows positive acute glucoregulatory effectss in diabetic obese monkeys .
    SAR441255
  • HY-P3138

    Angiotensin Receptor Cardiovascular Disease
    (Sar1)-Angiotensin II, an analogue of Angiotensin II, is a specific agonist of angiotensin AT1 receptor. (Sar1)-Angiotensin II binds to brain membrane-rich particles, with a Kd of 2.7 nM. (Sar1)-Angiotensin II can stimulate protein synthesis and cell growth in embryonic chick myocytes .
    (Sar1)-Angiotensin II
  • HY-137472

    GSK-3 Neurological Disease
    SAR502250 is a potent, selective, ATP competitive, orally active and brain-penetrant inhibitor of GSK3, with an IC50 of 12 nM for human GSK-3β. SAR502250 displays antidepressant-like activity. SAR502250 can be used for the research of Alzheimer’s disease (AD) .
    SAR502250
  • HY-100895
    SAR-20347
    1 Publications Verification

    JAK Cancer
    SAR-20347 is an inhibitor of TYK2, JAK1, JAK2 and JAK3 with IC50s of 0.6, 23, 26 and 41 nM, respectively.
    SAR-20347
  • HY-118653

    MAGL Metabolic Disease
    SAR629 is a potent monoglyceride lipase (MGL) covalent inhibitor. SAR629 also inhibits 2-Arachidonoylglycerol (2-AG) degradation .
    SAR629
  • HY-169340

    Adrenergic Receptor Inflammation/Immunology
    SAR-150640, a selective β3-adrenoceptor agonist, prevents the increase in MMP activity and production observed after LPS stimulation or in cases of chorioamnionitis .
    SAR-150640
  • HY-16446

    c-Met/HGFR PI3K Akt MEK Apoptosis Cancer
    SAR125844 is a potent, selective, and ATP-competitive MET kinase inhibitor with the value of IC50 is 4.2 nM and Ki is 2.8 nM. SAR125844 has antitumor activity and can be used for the research of cancer .
    SAR125844
  • HY-15458
    SAR131675
    5+ Cited Publications

    VEGFR Cancer
    SAR131675 is a potent and selective VEGFR3 inhibitor with an IC50 of 23 nM. SAR131675 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
    SAR131675
  • HY-15687A
    SAR407899
    3 Publications Verification

    ROCK Metabolic Disease
    SAR407899 is a selective, potent and ATP-competitive ROCK inhibitor, with an IC50 of 135 nM for ROCK-2, and Kis of 36 nM and 41 nM for human and rat ROCK-2, respectively. SAR407899 shows stable inhibition of migrasome formation.
    SAR407899
  • HY-P10031A

    GLP Receptor GCGR Metabolic Disease
    SAR441255 TFA is a potent unimolecular peptide GLP-1/GIP/GCG receptor triagonist. SAR441255 TFA displays high potency with balanced activation of all three target receptors.?SAR441255 TFA shows positive acute glucoregulatory effectss in diabetic obese monkeys .
    SAR441255 TFA
  • HY-133017
    Amcenestrant
    3 Publications Verification

    SAR439859

    Estrogen Receptor/ERR Cancer
    SAR439859 (compound 43d) is an orally active, non-steroidal, and selective estrogen receptor degrader (SERD). SAR439859 is an effective ER antagonist with ER degradation activity, an EC50 of 0.2 nM. SAR439859 can show potent anti-tumor effects and limited cross-resistance in ER + breast cancer.
    Amcenestrant
  • HY-12605S

    Isotope-Labeled Compounds Thrombin Metabolic Disease
    SAR107375-d11 (Tartrate) is deuterium labeled SAR107375. SAR107375 is a potent and orally active dual thrombin and factor Xa inhibitor, with Ki values of 1 nM and 8 nM for factor Xa and thrombin, respectively .
    SAR107375-d11 Tartrate
  • HY-18986
    SAR405838
    2 Publications Verification

    MI-77301

    MDM-2/p53 E1/E2/E3 Enzyme Apoptosis Cancer
    SAR405838 (MI-77301), an analog of MI-773, is a highly potent and selective MDM2-p53 interaction inhibitor. SAR405838 binds to MDM2 with a Ki of 0.88 nM. SAR405838 induces apoptosis and has potent antitumor activity .
    SAR405838
  • HY-P4475

    Thrombin Cardiovascular Disease
    Sar-Pro-Arg-pNA is a chromogenic substrate of α-thrombin. Sar-Pro-Arg-pNA can be used to test α-thrombin activity .
    Sar-Pro-Arg-pNA
  • HY-15699A
    SAR7334 hydrochloride
    15+ Cited Publications

    TRP Channel Neurological Disease
    SAR7334 hydrochloride is a potent and specific TRPC6 inhibitor, inhibiting TRPC6 currents with IC50 of 7.9 nM.
    SAR7334 hydrochloride
  • HY-15699
    SAR7334
    15+ Cited Publications

    TRP Channel Neurological Disease
    SAR7334 is a potent and specific TRPC6 inhibitor, inhibiting TRPC6 currents with IC50 of 7.9 nM.
    SAR7334
  • HY-12481
    SAR405
    20+ Cited Publications

    PI3K Autophagy Cancer
    SAR405 is a first-in-class, selective, and ATP-competitive PI3K class III (PIK3C3) isoform Vps34 inhibitor (IC50=1.2 nM; Kd=1.5 nM). SAR405 inhibits autophagy induced either by starvation or by mTOR inhibition. Anticancer activity .
    SAR405
  • HY-12605

    Thrombin Metabolic Disease
    SAR107375 is a potent and orally active dual thrombin and factor Xa inhibitor, with Ki values of 1 nM and 8 nM for factor Xa and thrombin, respectively .
    SAR107375
  • HY-151608

    SARS-CoV Infection
    SARS-CoV-2 Mpro-IN-3 is a potent M pro inhibitor with an IC50 value of ﹥5 μM. SARS-CoV-2 Mpro-IN-3 can be used in research of COVID-19 .
    SARS-CoV-2 Mpro-IN-3
  • HY-P4685

    Angiotensin Receptor Metabolic Disease
    (Sar1,Ile4,8)-Angiotensin II is a functionally selective angiotensin II type 1 receptor (AT1R) agonist. (Sar1,Ile4,8)-Angiotensin II potentiates insulin-stimulated insulin receptor (IR) signaling and glycogen synthesis. (Sar1,Ile4,8)-Angiotensin II potentiates insulin-stimulated phosphorylation of Akt and GSK3α/β .
    (Sar1,Ile4,8)-Angiotensin II
  • HY-132808

    SAR 444727; PRN473

    Btk Inflammation/Immunology
    Atuzabrutinib (SAR 444727) is a potent, selective reversible inhibitor of Btk (Bruton's tyrosine kinase) inhibitor. Atuzabrutinib inhibits neutrophil recruitment via inhibition of macrophage antigen-1 signalling .
    Atuzabrutinib
  • HY-P99883

    SAR156597

    Interleukin Related Others
    Romilkimab (SAR156597) is a chimeric humanized IG antibody that specifically targets IL-4 and IL13 .
    Romilkimab
  • HY-15687
    SAR407899 hydrochloride
    3 Publications Verification

    ROCK Metabolic Disease
    SAR407899 hydrochloride is a selective, potent and ATP-competitive ROCK inhibitor, with an IC50 of 135 nM for ROCK-2, and Kis of 36 nM and 41 nM for human and rat ROCK-2, respectively.
    SAR407899 hydrochloride
  • HY-166879S

    Isotope-Labeled Compounds Others
    SAR107375E Impurity 14-d8 is deuterium labeled SAR107375E Impurity 148 .
    SAR107375E Impurity 14-d8
  • HY-166878S

    Isotope-Labeled Compounds Others
    SAR107375E impurity 13-d8 is deuterium labeled SAR107375E impurity 138 .
    SAR107375E impurity 13-d8
  • HY-149955

    SARS-CoV Infection
    SARS-CoV-2-IN-38 (compound 24) is a SARS-CoV-2 inhibitor with good oral bioavailability in mice (F%=39.75%) .
    SARS-CoV-2-IN-38
  • HY-18986S

    MI-77301-d10

    Isotope-Labeled Compounds Cancer
    SAR405838-d10 (MI-77301-d10) is the deuterium labeled SAR405838 (HY-18986). SAR405838 (MI-77301), an analog of MI-773, is a highly potent and selective MDM2-p53 interaction inhibitor. SAR405838 binds to MDM2 with a Ki of 0.88 nM. SAR405838 induces apoptosis and has potent antitumor activity .
    SAR405838-d10
  • HY-P991183

    CD28 CD38 CD3 Cancer
    SAR442257 is a humanized IgG4-S228P, kappa monoclonal antibody targeting CD38 and CD28 on multiple myeloma cells and co-stimulates CD3 and CD28 on T cells .
    SAR-442257
  • HY-RS26995

    Small Interfering RNA (siRNA) Others

    Sar1a Rat Pre-designed siRNA Set A contains three designed siRNAs for Sar1a gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Sar1a Rat Pre-designed siRNA Set A
    Sar1a Rat Pre-designed siRNA Set A
  • HY-RS12442

    Small Interfering RNA (siRNA) Others

    SAR1A Human Pre-designed siRNA Set A contains three designed siRNAs for SAR1A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    SAR1A Human Pre-designed siRNA Set A
    SAR1A Human Pre-designed siRNA Set A
  • HY-RS20487

    Small Interfering RNA (siRNA) Others

    Sar1a Mouse Pre-designed siRNA Set A contains three designed siRNAs for Sar1a gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Sar1a Mouse Pre-designed siRNA Set A
    Sar1a Mouse Pre-designed siRNA Set A
  • HY-150691

    SARS-CoV Cancer
    SARS 3CLpro-IN-1 (Compound 3b) is a SARS 3CL protease inhibitor with an IC50 value of 95 μM, as a specific stereo isomer of the octahydroisochromene scaffold, directs the P1 site imidazole .
    SARS 3CLpro-IN-1
  • HY-19344
    Lifitegrast
    5+ Cited Publications

    SAR 1118; SHP-606

    Integrin Inflammation/Immunology
    Lifitegrast (SAR 1118) is a potent integrin antagonist. Lifitegrast blocks the binding of intercellular adhesion molecule 1 (ICAM-1) to lymphocyte function-associated antigen 1 (LFA-1), interrupting the T cell-mediated inflammatory cycle. Lifitegrast inhibits Jurkat T cell attachment to ICAM-1 with an IC50 of 2.98 nM. Lifitegrast can be used for researching dry eye disease .
    Lifitegrast
  • HY-19344A
    Lifitegrast sodium
    5+ Cited Publications

    SAR 1118 sodium; SHP-606 sodium

    Integrin Inflammation/Immunology
    Lifitegrast (SAR 1118) sodium is a potent integrin antagonist. Lifitegrast sodium blocks the binding of intercellular adhesion molecule 1 (ICAM-1) to lymphocyte function-associated antigen 1 (LFA-1), interrupting the T cell-mediated inflammatory cycle. Lifitegrast sodium inhibits Jurkat T cell attachment to ICAM-1 with an IC50 of 2.98 nM. Lifitegrast sodium can be used for researching dry eye disease .
    Lifitegrast sodium
  • HY-RS12443

    Small Interfering RNA (siRNA) Others

    SAR1B Human Pre-designed siRNA Set A contains three designed siRNAs for SAR1B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    SAR1B Human Pre-designed siRNA Set A
    SAR1B Human Pre-designed siRNA Set A
  • HY-155308

    SARS-CoV Infection
    SARS-CoV-2-IN-61 (compound 8i) is a SARS CoV-2 PLpro inhibitor with an IC50 of 16 µM. SARS-CoV-2-IN-61 has antiviral activities .
    SARS-CoV-2-IN-61
  • HY-P991082

    SAR-428926 antibody

    Transmembrane Glycoprotein Cancer
    Anti-LAMP1/CD107a Antibody (SAR-428926 antibody) is an anti-LAMP1 humanized monoclonal antibody. Anti-LAMP1/CD107a Antibody can be used for the antibody part of SAR-428926. Antibody Anti-LAMP1/CD107a Antibody can be referenced as Human IgG1 kappa, Isotype Control (HY-P99001) .
    Anti-LAMP1/CD107a Antibody
  • HY-P0205A

    [SAR1,Ala8] Angiotensin II acetate hydrate

    Angiotensin Receptor Cardiovascular Disease Inflammation/Immunology
    Saralasin ([Sar1,Ala8] Angiotensin II) acetate hydrate is an octapeptide analog of angiotensin II. Saralasin acetate hydrate is a competitive angiotensin II receptor antagonist with a Ki value of 0.32 nM for 74% of the binding sites, and has partial agonist activity as well. Saralasin acetate hydrate can be used for the research of renovascular hypertension, renin-dependent (angiotensinogenic) hypertension .
    Saralasin acetate hydrate
  • HY-P0205

    [SAR1,Ala8] Angiotensin II

    Angiotensin Receptor Cardiovascular Disease Inflammation/Immunology
    Saralasin ([Sar1,Ala8] Angiotensin II) is an octapeptide analog of angiotensin II. Saralasin is a competitive angiotensin II receptor antagonist with a Ki value of 0.32 nM for 74% of the binding sites, and has partial agonist activity as well. Saralasin can be used for the research of renovascular hypertension, renin-dependent (angiotensinogenic) hypertension .
    Saralasin
  • HY-P990091

    SAR 445088

    Complement System Inflammation/Immunology
    Riliprubart (SAR 445088) is an anti-C1s humanized IgG4 monoclonal antibody that inhibits activated C1s in the proximal portion of the classical complement system. Riliprubart selectively inhibits activated C1s and prevents the enzymatic action of C1 on its substrates C4 and C2, thus inhibiting the formation of the classical pathway C3 convertase, C4b2a. Riliprubart can be used to study complement-mediated diseases such as systemic lupus erythematosus. Recommend Isotype Controls: Human IgG4 (S228P) kappa, Isotype Control (HY-P99003) .
    Riliprubart

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: